The effect of obesity on chronic respiratory diseases : pathophysiology and therapeutic strategies

DC FieldValueLanguage
dc.contributor.authorPoulain, Magali-
dc.contributor.authorDoucet, Mariève-
dc.contributor.authorMajor, Geneviève-
dc.contributor.authorDrapeau, Vicky-
dc.contributor.authorSériès, Frédéric-
dc.contributor.authorBoulet, Louis-Philippe-
dc.contributor.authorTremblay, Angelo-
dc.contributor.authorMaltais, François-
dc.description.abstractSedentary lifestyles and increased pollution brought about by industrialization pose major challenges to the prevention of both obesity and chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, obstructive sleep apnea and obesity hypoventilation syndrome. Obesity has emerged as an important risk factor for these respiratory diseases, and in many instances weight loss is associated with important symptomatic improvement. Moreover, obesity may influence the development and presentation of these diseases. In this article, we review the current understanding of the influence of obesity on chronic respiratory diseases and the clinical management of obesity concurrent with asthma, COPD, obstructive sleep apnea or obesity hypoventilation
dc.publisherCanadian Medical Associationfr
dc.titleThe effect of obesity on chronic respiratory diseases : pathophysiology and therapeutic strategiesfr
dc.typeCOAR1_1::Texte::Périodique::Revue::Contribution à un journal::Article::Article de recherchefr
dcterms.bibliographicCitationCanadian medical association journal, Vol. 174 (9), 1293–1299 (2006)fr
dc.audienceProfesseurs (Enseignement supérieur)fr
dc.subject.rvmObésité -- Aspect physiologiquefr
dc.subject.rvmAppareil respiratoire -- Maladiesfr
dc.subject.rvmMaladies chroniquesfr
rioxxterms.versionVersion of Recordfr
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
Poulain et al_2006.pdf
258.46 kBAdobe PDF    Request a copy
All documents in CorpusUL are protected by Copyright Act of Canada.